Dragon Pharmaceuticals Inc.

dragon pharmaceuticals inc. - All News and Analysis

• Dragon Pharma Reports 2008 Third Quarter Financial Results

  - 2008-11-14

  Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company") (TSX: DDD)(OTCBB: DRUG)(BBSE: DRP), a leading international pharmaceutical company, today announced its financial results for the third quarter and nine months ended September 30, 2008. Sales for the third quarter increased 54% over the same period last year to $35.48 million with...

• BellwetherReport.com Analyst Opinions on BSRC, CRWG, DRUG and UTVG

  - 2008-09-03

  BellwetherReport.com is the leading onlinefinancial newsletter for investors seeking top independent and unbiasedresearch. Investors seeking free and unbiased analyst opinions on thecompanies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports.Today, we have once again scheduled interviews with a...

• Dragon Pharma Reports 2008 Record Second Quarter Financial Results

  - 2008-08-14

  Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company") (TSX: DDD)(OTCBB: DRUG)(BBSE: DRP), a leading international pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2008, achieving earnings per share ("EPS") of $0.04 for the quarter and $0.07 for the first half of the year. In...

• Dragon Pharma Reports 2008 Record First Quarter Financial Results

  - 2008-05-14

  Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company") (TSX: DDD)(OTCBB: DRUG)(BBSE: DRP), a leading international pharmaceutical company, today announced its financial results for the first quarter ended March 31, 2008, achieving record growth in both revenue and net profit, with an earnings per share ("EPS") of $0.03 for the quarter....

• Dragon Pharma Announces Strategic Realignment of its Business Segments into Two Divisions: Cephalosporin and Penicillin

  - 2008-04-22

  Dragon Pharmaceutical Inc. ("Dragon" or the "Company") (TSX: DDD)(OTCBB: DRUG)(BBSE: DRP), a leading international pharmaceutical company, today announced that beginning with the first quarter of 2008, the Company has realigned its business segments into two divisions: Cephalosporin and Penicillin. This realignment better reflects the Company's business strategy to become a...

• Dragon Pharma Announces 2007 Full Year Financial Results.

  - 2008-03-31

  VANCOUVER, BRITISH COLUMBIA, Mar 31, 2008 Marketwire via COMTEX -- Dragon Pharmaceutical Inc. ("Dragon" or the "Company") (TSX:DDD)(OTCBB:DRUG)(BBSE:DRP), a leading international pharmaceutical company, today announced its financial results for the fiscal year ended December 31, 2007. 2007 Full Year Financial Highlights: ...

• Progressive Review for Dragon Pharmaceutical Inc.

  - 2008-03-17

  M2 PRESSWIRE-17 March 2008-Market Review: Progressive Review for Dragon Pharmaceutical Inc.C1994-2008 M2 COMMUNICATIONS LTD RDATE:17032008 Streetinvesting.com has now resumed our progressive review of Dragon Pharmaceutical Inc. (TSX:DDD), after it traded unchanged Monday, early in the morning with no volume....

• Dragon Retains Leading Investor Relations Firm.

  - 2008-03-17

  VANCOUVER, BRITISH COLUMBIA, Mar 17, 2008 Marketwire via COMTEX -- Dragon Pharmaceutical Inc. ("Dragon" or the "Company") (TSX:DDD)(OTCBB:DRUG)(BBSE:DRP), a leading international pharmaceutical company, today announced it has retained cQuest, a capital markets advisory affiliate of Christensen, to facilitate and execute its investor and media relations...

• Investment Watch: ELHI! March 7, 2008.

  - 2008-03-07

  M2 PRESSWIRE-7 March 2008-Wall Street News Alert: Investment Watch: ELHI! March 7, 2008C1994-2008 M2 COMMUNICATIONS LTD RDATE:07032008 Weston, FLA. -- Wall Street News Alert's "stocks to watch" this morning are: Edgeline Holdings, Inc. (OTCBB: ELHI), e.Digital Corporation (OTCBB: EDIG),...

• Introduces Dragon Pharmaceutical to our Small Cap Radar.

  - 2008-03-06

  M2 PRESSWIRE-6 March 2008-Stock Targets: Introduces Dragon Pharmaceutical to our Small Cap RadarC1994-2008 M2 COMMUNICATIONS LTD RDATE:06032008 International Stock Targets is a world renowned independent research firm, based in Johannesburg, South Africa. Along with walking investors through the whole...

• Dragon Announces New Product Launch; Increase in Annual Production Output Capacity.

  - 2008-03-05

  VANCOUVER, BRITISH COLUMBIA, Mar 5, 2008 Marketwire via COMTEX -- Dragon Pharmaceutical Inc. ("Dragon" or the "Company") (TSX:DDD)(OTCBB:DRUG)(BBSE:DRP), a leading international pharmaceutical company, today announced the Company has increased its annual production capacity for its core products 7ACA and Clavulanic Acid by 30% and 56%...

• Sterling Adds to Executive & Mine Management Teams

  - 2008-01-02

  Sterling Mining Company (TSX: SMQ)(OTCBB: SRLM)(FRANKFURT: SMX) today announced the appointment of Matthew Kavanagh as the Company's new Vice President Corporate Development as well as the promotions of Fred Peck and Mike McLean. Mr. Kavanagh is a Chartered Accountant with 20 years of extensive experience in finance and Canadian markets,...

• Dragon Achieved Solid Increase in Sales and Profits from Continuing Operations for Q3.

  - 2007-11-14

  VANCOUVER, BRITISH COLUMBIA, Nov 14, 2007 Marketwire via COMTEX -- Dragon Pharmaceutical Inc. (TSX:DDD)(OTCBB:DRUG)(BBSE:DRP) today announced its financial results for the three and nine months ended September 30, 2007, showing strong growth in sales and profits for its core antibiotic business. Meanwhile, the Company also announced...

• Dragon Sells EPO Business; Focus on Antibiotic Core Business.

  - 2007-11-14

  VANCOUVER, BRITISH COLUMBIA, Nov 14, 2007 Marketwire via COMTEX -- Dragon Pharmaceutical Inc. (TSX:DDD)(OTCBB:DRUG)(BBSE:DRP) today announced that it has entered an agreement with an unaffiliated party for the sale of its EPO business which accounted for less than 3% of Dragon's consolidated revenue for the first...

• Dragon Announces R&D Achievement in Biotech Manufacturing Process.

  - 2007-10-31

  VANCOUVER, BRITISH COLUMBIA, Oct 31, 2007 Marketwire via COMTEX -- Dragon Pharmaceutical Inc. (TSX:DDD)(OTCBB:DRUG)(BBSE:DRP) today announced that its biotech method for 7ACA production has been successfully implemented on a new production line. Management believes this achievement validates the Company's research and development efforts to improve...

• Strong Demand Pushes up Both Prices and Sales Volumes for Dragon's Main Products.

  - 2007-10-03

  VANCOUVER, BRITISH COLUMBIA, Oct 3, 2007 Marketwire via COMTEX -- Dragon Pharmaceutical Inc. (TSX:DDD)(OTCBB:DRUG)(BBSE:DRP) today announces major increase in both prices and sales volumes for its main products. Further, under favorable market conditions, the Company has been operating near its maximum capacity to meet rising customer...

• Dragon Pharmaceutical Reports Growth in Sales and Profits During Second Quarter of 2007.

  - 2007-08-14

  VANCOUVER, BRITISH COLUMBIA, Aug 14, 2007 CCNMatthews via COMTEX -- Dragon Pharmaceutical Inc. (TSX:DDD)(OTCBB:DRUG)(BBSE:DRP) today announced the financial results for the second quarter ended June 30, 2007. Highlights of the Second Quarter, 2007 - Sales increased 48% to $20.55...

• Dragon Announces August 13, 2007 for 2007 Annual Stockholders Meeting.

  - 2007-07-10

  VANCOUVER, BRITISH COLUMBIA, Jul 10, 2007 CCNMatthews via COMTEX -- Dragon Pharmaceutical Inc. (TSX:DDD)(OTCBB:DRUG)(BBSE:DRP) ("the Company") is pleased to announce that August 13, 2007 has been set as the date for the Annual Stockholders meeting. The Annual Meeting of Dragon stockholders will be...

• Dragon Issued Restricted Shares.

  - 2007-07-03

  VANCOUVER, BRITISH COLUMBIA, Jul 3, 2007 CCNMatthews via COMTEX -- Dragon Pharmaceutical Inc. (TSX:DDD)(OTCBB:DRUG)(BBSE:DRP) today announced the sale of 3,496,503 shares of restricted common stock to a vendor at an offering price of $0.429 per share, with a total of US$1.5 million. The transaction was completed...

• Dragon Pharmaceutical Announces Operating Income of $1.79m for the First Quarter.

  - 2007-05-16

  VANCOUVER, BRITISH COLUMBIA, May 16, 2007 CCNMatthews via COMTEX -- Dragon Pharmaceutical Inc. (TSX:DDD)(OTCBB:DRUG)(BBSE:DRP) today announced the financial results for the first quarter ended March 31, 2007. First Quarter Highlights - Sales increased 32% to $17.33 million from $13.15...

• Incorporated: 1989
• CEO: Mr. Yanlin Han
• Employees: 2,113